PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 152 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $734,000 | -25.4% | 193,265 | 0.0% | 0.01% | +50.0% |
| Q4 2019 | $984,000 | -10.1% | 193,265 | -10.7% | 0.01% | -14.3% |
| Q3 2019 | $1,094,000 | -5.1% | 216,465 | +15.8% | 0.01% | -22.2% |
| Q2 2019 | $1,153,000 | +238.1% | 186,925 | +154.2% | 0.01% | +200.0% |
| Q1 2019 | $341,000 | +10.4% | 73,525 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $309,000 | -15.1% | 73,525 | +26.7% | 0.00% | 0.0% |
| Q3 2018 | $364,000 | -5.2% | 58,025 | +21.5% | 0.00% | 0.0% |
| Q2 2018 | $384,000 | +15.7% | 47,757 | +7.4% | 0.00% | +50.0% |
| Q1 2018 | $332,000 | +25.3% | 44,457 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $265,000 | -19.0% | 44,457 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $327,000 | +32.9% | 44,457 | +22.8% | 0.00% | -50.0% |
| Q2 2017 | $246,000 | -48.6% | 36,194 | -28.7% | 0.00% | -50.0% |
| Q1 2017 | $479,000 | – | 50,794 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|